The Lancet in conversation with
Een podcast door The Lancet Group - Vrijdagen
Categorieën:
656 Afleveringen
-
The Lancet-Tsinghua Healthy Cities Commission
Gepubliceerd: 19-4-2018 -
Malaria nets and insecticide resistance
Gepubliceerd: 12-4-2018 -
NCDs and economics
Gepubliceerd: 5-4-2018 -
Low back pain
Gepubliceerd: 22-3-2018 -
Pathology and laboratory medicine
Gepubliceerd: 15-3-2018 -
Global health journalism
Gepubliceerd: 9-3-2018 -
Canada's global leadership on health
Gepubliceerd: 23-2-2018 -
Virtual reality and surgical training
Gepubliceerd: 16-2-2018 -
Global health in 2018: The Lancet: January 23, 2018
Gepubliceerd: 23-1-2018 -
Rohingya in Malaysia: The Lancet: January 11, 2018
Gepubliceerd: 12-1-2018 -
Gene therapy for retinal dystrophy: The Lancet: January 5, 2018
Gepubliceerd: 6-1-2018 -
You don't know me: The Lancet: December 23, 2017
Gepubliceerd: 22-12-2017 -
Public availability of trial protocols: The Lancet: December 16, 2017
Gepubliceerd: 15-12-2017 -
Weight management in type 2 diabetes: The Lancet: December 5, 2017
Gepubliceerd: 5-12-2017 -
Liver disease: The Lancet: November 29, 2017
Gepubliceerd: 29-11-2017 -
Heart failure incidence: The Lancet: November 21, 2017
Gepubliceerd: 22-11-2017 -
Lancet Countdown 2017: The Lancet: October 30, 2017
Gepubliceerd: 31-10-2017 -
Conflict in Colombia: The Lancet: October 26, 2017
Gepubliceerd: 27-10-2017 -
The Lancet Commission on Pollution and Health: October 19, 2017
Gepubliceerd: 20-10-2017 -
Palliative Care and Pain Relief: The Lancet: October 12, 2017
Gepubliceerd: 13-10-2017
Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.